Fundz

Mantra Bio Raises $9 Million In Series A-2 Financing To Advance Development Of Lead Targeted Exosome Therapeutics Program

PRIVATEJan 04, 2023

Amount Raised

$9 Million

Round Type

Series A

San FranciscoManufacturingBiotechnologyArtificial IntelligenceTherapeutics

Description

Mantra Bio today announced it has raised $9 million in a Series A-2 financing to advance the development of its lead targeted exosome therapeutics program. New investor, Samsung Securities, joined existing investors, including 8VC, Viking Global Investors, Illumina, BoxGroup and Allen & Company in the financing round. The company's overall Series A funding, including a $25 million Series A-1, totals $34 million.

Quick answer

Mantra Bio raised $9 Million in a Series A round, dated January 4, 2023. Mantra Bio is based in San Francisco, California, United States.

How much did Mantra Bio raise?
Mantra Bio raised $9 Million in a Series A round on January 4, 2023.
What does Mantra Bio do?
Mantra Bio is developing next generation, targeted therapeutics based on its proprietary exosome engineering platform, REVEAL™.
Where is Mantra Bio based and how big is it?
Mantra Bio is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Manufacturing around the same time

Companies in the same sectors as Mantra Bio that raised within 45 days of this round, from Fundz verified event records.

  • Pathos AI raised $20M on February 17, 2023.
  • Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
  • MasterControl raised $150M (Series A) on December 15, 2022.
  • NewcelX raised $10M on December 13, 2022.
  • Alpha Cognition raised $1.8M (Seed) on February 16, 2023.
  • CardioMech AS raised $4.5M (Seed) on February 16, 2023.

Who to call at Mantra Bio, and when

A new round usually means Mantra Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mantra Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mantra Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mantra Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mantra Bio

Location

455 MISSION BAY BLVD SOUTH

San Francisco, California, United States

About

Mantra Bio is developing next generation, targeted therapeutics based on its proprietary exosome engineering platform, REVEAL™. The REVEAL™ platform, which integrates computational biology and bench lab automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics can be reproducibly made at high purity, consistency, and yield. The company's initial pipeline includes engineered exosome therapeutics in the areas of ophthalmology and infectious diseases. Investors include 8VC, Viking Global Investors, Samsung Securities, BoxGroup, Allen & Company LLC, and Illumina. Learn more about Mantra Bio at www.mantrabio.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mantra Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mantra Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Mantra Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.